Evidence map›Paper›PMID 31142767›Full record

ArticleScientific reports2019

Anephrogenic phenotype induced by SALL1 gene knockout in pigs.

Masahito Watanabe, Kazuaki Nakano, Ayuko Uchikura, Hitomi Matsunari, Sayaka Yashima, Kazuhiro Umeyama, Shuko Takayanagi, Tetsushi Sakuma, Takashi Yamamoto, Sumiyo Morita and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. The making of cells and organs in xenogeneic animal bioreactor.Signal transduction and targeted therapy · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. One-Step In Vitro Generation of ETV2-Null Pig Embryos.Animals : an open access journal from MDPI · 2022
    Article
  8. International journal of stem cells · 2022
    Review
  9. Pigs with δ-sarcoglycan deficiency exhibit traits of genetic cardiomyopathy.Laboratory investigation; a journal of technical methods and pathology · 2020
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Masahito WatanabeMeiji University International Institute for Bio-Resource Research, Kawasaki, 214-8571, Japan.
Kazuaki NakanoLaboratory of Developmental Engineering, Meiji University, Kawasaki, 214-8571, Japan.
Ayuko UchikuraLaboratory of Developmental Engineering, Meiji University, Kawasaki, 214-8571, Japan.
Hitomi MatsunariMeiji University International Institute for Bio-Resource Research, Kawasaki, 214-8571, Japan.
Sayaka YashimaLaboratory of Developmental Engineering, Meiji University, Kawasaki, 214-8571, Japan.
Kazuhiro UmeyamaMeiji University International Institute for Bio-Resource Research, Kawasaki, 214-8571, Japan.
Shuko TakayanagiLaboratory of Developmental Engineering, Meiji University, Kawasaki, 214-8571, Japan.
Tetsushi SakumaDepartment of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, 739-8526, Japan.
Takashi YamamotoDepartment of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, 739-8526, Japan.
Sumiyo MoritaLaboratory of Genome Science, Biosignal Genome Resource Center, Institute for Molecular and Cellular Regulation, Gunma University, Gunma, 371-8512, Japan.
Takuro HoriiLaboratory of Genome Science, Biosignal Genome Resource Center, Institute for Molecular and Cellular Regulation, Gunma University, Gunma, 371-8512, Japan.
Izuho HatadaLaboratory of Genome Science, Biosignal Genome Resource Center, Institute for Molecular and Cellular Regulation, Gunma University, Gunma, 371-8512, Japan.
Ryuichi NishinakamuraDepartment of Kidney Development, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, 860-0811, Japan.
Hiromitsu NakauchiDivision of Stem Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan.
Hiroshi NagashimaMeiji University International Institute for Bio-Resource Research, Kawasaki, 214-8571, Japan. hnagas@meiji.ac.jp.
Meiji University · JPGunma University · JPHiroshima University · JPKumamoto University · JPStanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To combat organ shortage in transplantation medicine, a novel strategy has been proposed to generate human organs from exogenous pluripotent stem cells utilizing the developmental mechanisms of pig embryos/foetuses. Genetically modified pigs missing specific organs are key elements in this strategy. In this study, we demonstrate the feasibility of using a genome-editing approach to generate anephrogenic foetuses in a genetically engineered pig model. SALL1 knockout (KO) was successfully induced by injecting genome-editing molecules into the cytoplasm of pig zygotes, which generated the anephrogenic phenotype. Extinguished SALL1 expression and marked dysgenesis of nephron structures were observed in the rudimentary kidney tissue of SALL1-KO foetuses. Biallelic KO mutations of the target gene induced nephrogenic defects; however, biallelic mutations involving small in-frame deletions did not induce the anephrogenic phenotype. Through production of F1 progeny from mutant founder pigs, we identified mutations that could reliably induce the anephrogenic phenotype and hence established a line of fertile SALL1-mutant pigs. Our study lays important technical groundwork for the realization of human kidney regeneration through the use of an empty developmental niche in pig foetuses.

Indexed as

Animals, Genetically ModifiedAllograftsAnimalsCRISPR-Cas SystemsFeasibility StudiesFemaleFetal DevelopmentGene EditingGene Expression Regulation, DevelopmentalGene Knockout TechniquesHumansKidney TransplantationMaleMutationNephronsPluripotent Stem CellsTranscription Activator-Like Effector NucleasesTranscription Factors

Identifiers

PMID31142767
PMCPMC6541644
OpenAlexW2946906489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.